Medicinal products for human use – Application for marketing authorisation for the medicinal product Fanaptum – iloperidone – Commission refusal decision – Regulation (EC) No 726/2004 – Scientific evaluation of the risks and benefits of a medicinal product – Obligation to state reasons – Manifest error of assessment – Proportionality – Equal treatment
ECLI:EU:T:2019:892, [2019] EUECJ T-211/18
Bailii
European
Updated: 19 July 2021; Ref: scu.665531 br>